NCT00158093View on ClinicalTrials.gov

A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo

PHASE1CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

July 31, 2003

Conditions
Hypertension
Interventions
DRUG

Nebivolol

DRUG

Atenolol

DRUG

Moxifloxacin

Trial Locations (1)

33181

SFBC International, Inc., Miami

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY